CI Investments Inc’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-145
Closed -$6K 1356
2023
Q2
$6K Buy
145
+139
+2,317% +$5.62K ﹤0.01% 1247
2023
Q1
$0 Hold
6
﹤0.01% 1361
2022
Q4
$0 Hold
6
﹤0.01% 1415
2022
Q3
$0 Hold
6
﹤0.01% 1402
2022
Q2
$0 Hold
6
﹤0.01% 1459
2022
Q1
$0 Sell
6
-111,948
-100% -$9.47M ﹤0.01% 1481
2021
Q4
$11.5M Sell
111,954
-19,488
-15% -$1.87M 0.04% 271
2021
Q3
$11.5M Buy
131,442
+6
+0% +$543 0.04% 281
2021
Q2
$11.8M Buy
+131,436
New +$11.1M 0.04% 277

Other funds holding SYNH

CI Investments Inc's SYNH Position: Q3 2023 in Review

CI Investments Inc sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 145 shares — an estimated $6K sold.

CI Investments Inc first reported a position in SYNH in Q2 2021 and held it in 9 quarters. The position peaked at $11.8M in Q2 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • CI Investments Inc reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • CI Investments Inc sold 145 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $6K.
  • CI Investments Inc first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2021 and held it in 9 quarters.
  • CI Investments Inc's Syneos Health, Inc. Class A Common Stock position peaked at $11.8M in Q2 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on CI Investments Inc's 13F filing for Q3 2023, filed 13 Nov 2023.